P-Cure Ltd
PrivateLast Round
Series D
Extension
May 17, 2023
Est. Valuation
$33.58M
Total Funding Raised
$40M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
P-Cure Ltd operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series D Extension round in May 2023.
P-Cure Ltd is a medical technology company that develops and provides compact, gantry-less proton therapy systems for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
P-Cure Ltd Comparables
Compare P-Cure Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| B dot Medical Inc. | 89% | |
| Mevion Medical Systems | 87% | |
| Leo Cancer Care | 86% |
For institutional investors. Book with your work email.
P-Cure Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | May 17, 2023 | ||||
| Series D | Jan 10, 2022 | ||||
| VC Round | Feb 1, 2021 | ||||
| Series B | Jul 16, 2019 | ||||
| Series A | Jan 16, 2017 | ||||
Series A | Dec 15, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2026
Developing first compact upright dual-modality proton and helium ion therapy platform.
- Nov 7, 2026
Partnering with UT MD Anderson on proton therapy platform development.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 9, 2026
P-Cure Ltd. and the University of Texas (UT) MD Anderson Cancer Center announce a strategic alliance to develop and clinically validate a compact, upright platform that delivers proton and helium ion therapy, starting with proton therapy evaluation before preclinical and clinical helium ion research.
- is_developingNov 7, 2026
On Aug 11th '26, P-Cure Ltd. collaborates with UT MD Anderson to advance development and clinical validation of a compact upright platform that delivers proton and helium ion therapy, initially focusing on proton therapy before preclinical and clinical helium ion programs.
- expands_offices_toSep 16, 2026
P-Cure Ltd. makes its first deployment in India through a planned multi-site proton therapy network, starting with a centre in Bengaluru and extending to Kochi and beyond.
For institutional investors. Book with your work email.
P-Cure Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about P-Cure Ltd's valuation, stock price, and market status.
Is P-Cure Ltd a public or private company?
P-Cure Ltd is a private company.
What is the current stock price of P-Cure Ltd?
P-Cure Ltd is a private company, so its shares have no public market price. Caplight tracks P-Cure Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is P-Cure Ltd worth (valuation)?
P-Cure Ltd's valuation is estimated at $33.6M based on funding round data.
Can I buy P-Cure Ltd stock?
P-Cure Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was P-Cure Ltd's last funding round?
P-Cure Ltd's most recent funding round was Series D Extension on May 17, 2023.
Who are the main investors in P-Cure Ltd?
Investor information for P-Cure Ltd is not publicly disclosed.
Will P-Cure Ltd IPO soon?
No public IPO plans have been announced for P-Cure Ltd.
How can I track P-Cure Ltd secondary market activity?
Caplight tracks bids, offers, and trades in P-Cure Ltd's shares on secondary markets.